SE0600091L - Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin - Google Patents
Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulinInfo
- Publication number
- SE0600091L SE0600091L SE0600091A SE0600091A SE0600091L SE 0600091 L SE0600091 L SE 0600091L SE 0600091 A SE0600091 A SE 0600091A SE 0600091 A SE0600091 A SE 0600091A SE 0600091 L SE0600091 L SE 0600091L
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- insulin
- controlled release
- dextran matrix
- implant
- Prior art date
Links
- 229920002307 Dextran Polymers 0.000 title abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000011159 matrix material Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000007943 implant Substances 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000011065 in-situ storage Methods 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0600091A SE529040C2 (sv) | 2006-01-18 | 2006-01-18 | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
PCT/SE2007/050027 WO2007084068A1 (en) | 2006-01-18 | 2007-01-17 | Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
JP2008551225A JP2009523791A (ja) | 2006-01-18 | 2007-01-17 | 1.0〜100kDaの分子量を有するデキストランを含む薬剤及びその調製方法 |
CNA2007800026635A CN101370523A (zh) | 2006-01-18 | 2007-01-17 | 方法和组合物 |
DE602007003315T DE602007003315D1 (de) | 2006-01-18 | 2007-01-17 | Pharmazeutische formulierungen mit dextran mit einem molekulargewicht von 1,0-100 kda und herstellungsverfahren dafür |
US12/161,324 US20080305139A1 (en) | 2006-01-18 | 2007-01-17 | Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation |
MX2008008924A MX2008008924A (es) | 2006-01-18 | 2007-01-17 | Formulaciones farmaceuticas que comprenden dextrano con peso molecular de 1.0-100kda y procesos para su preparacion. |
CA002636173A CA2636173A1 (en) | 2006-01-18 | 2007-01-17 | Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
AT07709420T ATE448798T1 (de) | 2006-01-18 | 2007-01-17 | Pharmazeutische formulierungen mit dextran mit einem molekulargewicht von 1,0-100 kda und herstellungsverfahren dafür |
AU2007206087A AU2007206087A1 (en) | 2006-01-18 | 2007-01-17 | Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kDa and processes for their preparation |
ES07709420T ES2336380T3 (es) | 2006-01-18 | 2007-01-17 | Formulacion farmaceuticas que comprenden dextrano con un peso molecular de 1,0-100 kda y procedimiento para su preparacion. |
BRPI0706543-4A BRPI0706543A2 (pt) | 2006-01-18 | 2007-01-17 | processo para preparação de uma composição adequada para a liberação controlada, e, artigo para aplicação biomédica |
EP07709420A EP1973570B1 (en) | 2006-01-18 | 2007-01-17 | Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
EP09175832A EP2153850A1 (en) | 2006-01-18 | 2007-01-17 | Liquid compositions comprising dextran, in situ formed implants obtained thereof |
RU2008133635/15A RU2008133635A (ru) | 2006-01-18 | 2007-01-17 | Способы и композиции |
TW096101920A TW200738279A (en) | 2006-01-18 | 2007-01-18 | Method and compositions |
ARP070100220A AR059071A1 (es) | 2006-01-18 | 2007-01-18 | Metodos y composicionesque comprenden dextrano con peso molecular de 1 a 100 kda |
HK09103041.4A HK1125041A1 (en) | 2006-01-18 | 2009-03-31 | Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
US12/510,533 US7781400B2 (en) | 2006-01-18 | 2009-07-28 | Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 KDA and processes for their preparation |
US12/724,158 US20100172950A1 (en) | 2006-01-18 | 2010-03-15 | Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 kda and processes for their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0600091A SE529040C2 (sv) | 2006-01-18 | 2006-01-18 | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0600091L true SE0600091L (sv) | 2007-04-17 |
SE529040C2 SE529040C2 (sv) | 2007-04-17 |
Family
ID=37930329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0600091A SE529040C2 (sv) | 2006-01-18 | 2006-01-18 | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
Country Status (17)
Country | Link |
---|---|
US (3) | US20080305139A1 (xx) |
EP (2) | EP1973570B1 (xx) |
JP (1) | JP2009523791A (xx) |
CN (1) | CN101370523A (xx) |
AR (1) | AR059071A1 (xx) |
AT (1) | ATE448798T1 (xx) |
AU (1) | AU2007206087A1 (xx) |
BR (1) | BRPI0706543A2 (xx) |
CA (1) | CA2636173A1 (xx) |
DE (1) | DE602007003315D1 (xx) |
ES (1) | ES2336380T3 (xx) |
HK (1) | HK1125041A1 (xx) |
MX (1) | MX2008008924A (xx) |
RU (1) | RU2008133635A (xx) |
SE (1) | SE529040C2 (xx) |
TW (1) | TW200738279A (xx) |
WO (1) | WO2007084068A1 (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA200501421A1 (ru) * | 2003-03-04 | 2006-04-28 | Дзе Текнолоджи Девелопмент Компани Лтд. | Пероральная композиция инсулина и способы её изготовления и применения |
US9023376B2 (en) * | 2008-06-27 | 2015-05-05 | The University Of Akron | Nanofiber-reinforced composition for application to surgical wounds |
KR101003331B1 (ko) | 2010-05-11 | 2010-12-23 | 조강선 | 피부 충전제 조성물 |
AU2015221390B2 (en) * | 2014-02-20 | 2019-03-07 | Ortho Regenerative Technologies Inc. | Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair |
US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
US10426796B2 (en) * | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713249A (en) * | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
SE8204244L (sv) | 1982-07-09 | 1984-01-10 | Ulf Schroder | Kristalliserad kolhydratsmatris for biologiskt aktiva substanser |
DE3500268A1 (de) * | 1985-01-05 | 1986-07-10 | Hoechst Ag, 6230 Frankfurt | Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung |
WO1987002704A1 (en) | 1985-10-22 | 1987-05-07 | Eric Robinson | Process for cell immobilisation |
JPS62152816A (ja) * | 1985-12-27 | 1987-07-07 | Sumitomo Pharmaceut Co Ltd | ゲル状高分子の成形方法 |
JPH0720483B2 (ja) * | 1987-05-29 | 1995-03-08 | 住友製薬株式会社 | 高粘度糊状組成物成形体の乾燥法 |
US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
US7087244B2 (en) | 2000-09-28 | 2006-08-08 | Battelle Memorial Institute | Thermogelling oligopeptide polymers |
WO2000018377A1 (en) | 1998-09-28 | 2000-04-06 | Warner-Lambert Company | Enteric and colonic delivery using hpmc capsules |
EP1074248A1 (en) | 1999-07-08 | 2001-02-07 | Arnold Hilgers | Delivery system for biological material |
US20030026844A1 (en) * | 2000-04-18 | 2003-02-06 | Hee-Yong Lee | Injectable sustained release pharmaceutical composition and processes for preparing the same |
EP1184032A1 (en) | 2000-08-31 | 2002-03-06 | OctoPlus B.V. | Dextran hydrogels |
CA2460867C (en) | 2001-09-19 | 2011-04-12 | Elan Pharma International Ltd. | Nanoparticulate insulin formulations |
EA200501421A1 (ru) * | 2003-03-04 | 2006-04-28 | Дзе Текнолоджи Девелопмент Компани Лтд. | Пероральная композиция инсулина и способы её изготовления и применения |
TW200603843A (en) * | 2004-04-20 | 2006-02-01 | Technology Dev Company Ltd | Tissue enhancement implant and method |
-
2006
- 2006-01-18 SE SE0600091A patent/SE529040C2/sv not_active IP Right Cessation
-
2007
- 2007-01-17 EP EP07709420A patent/EP1973570B1/en not_active Revoked
- 2007-01-17 DE DE602007003315T patent/DE602007003315D1/de active Active
- 2007-01-17 MX MX2008008924A patent/MX2008008924A/es not_active Application Discontinuation
- 2007-01-17 AT AT07709420T patent/ATE448798T1/de not_active IP Right Cessation
- 2007-01-17 EP EP09175832A patent/EP2153850A1/en not_active Withdrawn
- 2007-01-17 AU AU2007206087A patent/AU2007206087A1/en not_active Abandoned
- 2007-01-17 CN CNA2007800026635A patent/CN101370523A/zh active Pending
- 2007-01-17 BR BRPI0706543-4A patent/BRPI0706543A2/pt not_active IP Right Cessation
- 2007-01-17 RU RU2008133635/15A patent/RU2008133635A/ru not_active Application Discontinuation
- 2007-01-17 ES ES07709420T patent/ES2336380T3/es active Active
- 2007-01-17 CA CA002636173A patent/CA2636173A1/en not_active Abandoned
- 2007-01-17 WO PCT/SE2007/050027 patent/WO2007084068A1/en active Application Filing
- 2007-01-17 JP JP2008551225A patent/JP2009523791A/ja active Pending
- 2007-01-17 US US12/161,324 patent/US20080305139A1/en not_active Abandoned
- 2007-01-18 TW TW096101920A patent/TW200738279A/zh unknown
- 2007-01-18 AR ARP070100220A patent/AR059071A1/es not_active Application Discontinuation
-
2009
- 2009-03-31 HK HK09103041.4A patent/HK1125041A1/xx not_active IP Right Cessation
- 2009-07-28 US US12/510,533 patent/US7781400B2/en not_active Expired - Fee Related
-
2010
- 2010-03-15 US US12/724,158 patent/US20100172950A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2153850A1 (en) | 2010-02-17 |
EP1973570A1 (en) | 2008-10-01 |
SE529040C2 (sv) | 2007-04-17 |
JP2009523791A (ja) | 2009-06-25 |
CA2636173A1 (en) | 2007-07-26 |
AR059071A1 (es) | 2008-03-12 |
TW200738279A (en) | 2007-10-16 |
MX2008008924A (es) | 2008-09-05 |
US7781400B2 (en) | 2010-08-24 |
ATE448798T1 (de) | 2009-12-15 |
EP1973570B1 (en) | 2009-11-18 |
CN101370523A (zh) | 2009-02-18 |
US20080305139A1 (en) | 2008-12-11 |
ES2336380T3 (es) | 2010-04-12 |
US20100172950A1 (en) | 2010-07-08 |
BRPI0706543A2 (pt) | 2011-03-29 |
HK1125041A1 (en) | 2009-07-31 |
RU2008133635A (ru) | 2010-02-27 |
DE602007003315D1 (de) | 2009-12-31 |
WO2007084068A1 (en) | 2007-07-26 |
AU2007206087A1 (en) | 2007-07-26 |
US20090281020A1 (en) | 2009-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0600091L (sv) | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin | |
CO6450686A2 (es) | Compuesto biocompatible y su uso | |
HK1107922A1 (en) | Suture with adhesive/sealant delivery mechanism | |
PH12016500606A1 (en) | Insulin preparations containing methionine | |
NI201200013A (es) | Composición de insulina de acción prolongada | |
WO2006079641A3 (en) | Insulin derivatives conjugated with structurally well defined branched polymers | |
CL2009001340A1 (es) | Compuesto de insulina lispro pegilada o una sal del mismo que comprende una cadena a de sec no:1, una cadena b de sec no:3 y el peg es de un peso entre 20 a 40 kda; uso de dicho compuesto para tratar hipoglicemia o diabetes; composición farmacéutica que comprende dicho compuesto; y proceso para elaborar dicho compuesto. | |
WO2010087971A3 (en) | Drug delivery and substance transfer facilitated by nano-enhanced device having aligned carbon nanotubes protruding from device surface | |
ZA201102350B (en) | Pyridin-2-yl-amino-i,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus | |
NO20091801L (no) | Peristatisk mikropumpe med utskiftbart pumpehode | |
PE20090472A1 (es) | Proceso para reducir la cantidad de componentes organicos en el agua usando carbonato de calcio que reacciona en la superficie en combinacion con un adsorbente hidrofobico, el cual se contacta con el agua a ser tratada | |
NZ604079A (en) | Safety device for a pre-filled syringe and injection device | |
AR080884A1 (es) | Conjugados de insulina-sirna | |
CL2008002255A1 (es) | Compuesto 3-({4-(2,2-difluoroetil)-3-(1h-pirrolo [2,3-b] piridin-5-il)-1h-pirazol-4-il] pirimidin-2-il}amino)propanonitrilo, inhibidor de raf; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del crecimiento celular anormal o cualquier enfermedad o afeccion mediada por raf. | |
WO2008063842A3 (en) | Methods of treating neuropathic pain with agonists of ppar-gamma | |
ATE419842T1 (de) | Abgabevehikel mit nanoteilchen | |
WO2006133102A3 (en) | Agent delivery system and uses of the same | |
AR080669A1 (es) | Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina | |
MX2010009154A (es) | Moleculas conjugadas del factor viii. | |
DE602006019517D1 (de) | Multi-Nährstoff Polymerdüngemittel mit langsamer und gesteuerter Freigabe des Nährstoffs , Verfahren zu dessen Herstellung und Verwendung desselben | |
RS52629B (en) | LIXISENATIDE AS ADDITIONAL THERAPY INSULIN GLARGINE AND METFORMIN FOR TYPE 2 DIABETES TREATMENT | |
HK1097774A1 (en) | Stable pharmaceutical composition comprising linezolid from iv | |
ATE467538T1 (de) | Fusseinrichtung zur abstützung einer stütz- oder hubeinrichtung | |
TW200741200A (en) | Humidity sensor | |
WO2011031827A3 (en) | Manufacture of extracellular matrix products using supercritical or near supercritical fluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |